JP2009536021A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009536021A5 JP2009536021A5 JP2009504310A JP2009504310A JP2009536021A5 JP 2009536021 A5 JP2009536021 A5 JP 2009536021A5 JP 2009504310 A JP2009504310 A JP 2009504310A JP 2009504310 A JP2009504310 A JP 2009504310A JP 2009536021 A5 JP2009536021 A5 JP 2009536021A5
- Authority
- JP
- Japan
- Prior art keywords
- sample
- ratio
- leukocytes
- mrna
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000265 leukocyte Anatomy 0.000 claims description 60
- 108020004999 messenger RNA Proteins 0.000 claims description 49
- 238000000034 method Methods 0.000 claims description 38
- 230000004936 stimulating effect Effects 0.000 claims description 36
- 238000000338 in vitro Methods 0.000 claims description 29
- 230000000638 stimulation Effects 0.000 claims description 18
- 238000002560 therapeutic procedure Methods 0.000 claims description 16
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 13
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 8
- 238000004587 chromatography analysis Methods 0.000 claims description 8
- 102000003390 tumor necrosis factor Human genes 0.000 claims description 8
- 241000282412 Homo Species 0.000 claims description 7
- 201000010099 disease Diseases 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- 238000013518 transcription Methods 0.000 claims description 2
- 230000035897 transcription Effects 0.000 claims description 2
- 230000002776 aggregation Effects 0.000 claims 12
- 238000004220 aggregation Methods 0.000 claims 12
- 239000003795 chemical substances by application Substances 0.000 claims 10
- 108010062580 Concanavalin A Proteins 0.000 claims 8
- 108010047620 Phytohemagglutinins Proteins 0.000 claims 8
- 108010046516 Wheat Germ Agglutinins Proteins 0.000 claims 8
- 239000002158 endotoxin Substances 0.000 claims 8
- 229920006008 lipopolysaccharide Polymers 0.000 claims 8
- PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical group C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 claims 8
- 230000001885 phytohemagglutinin Effects 0.000 claims 8
- 229920000855 Fucoidan Polymers 0.000 claims 4
- 210000004369 blood Anatomy 0.000 claims 4
- 239000008280 blood Substances 0.000 claims 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical group P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims 4
- 239000002953 phosphate buffered saline Substances 0.000 claims 4
- 229930105110 Cyclosporin A Natural products 0.000 claims 2
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims 2
- 108010036949 Cyclosporine Proteins 0.000 claims 2
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 claims 2
- 229960001265 ciclosporin Drugs 0.000 claims 2
- 108010084553 jacalin Proteins 0.000 claims 2
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 claims 2
- 229960001967 tacrolimus Drugs 0.000 claims 2
- 230000001747 exhibiting effect Effects 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79051106P | 2006-04-07 | 2006-04-07 | |
| PCT/US2007/008559 WO2007117589A2 (en) | 2006-04-07 | 2007-04-05 | Enhanced fc receptor-mediated tumor necrosis factor superfamily and chemokine mrna expression in peripheral blood leukocytes in patients with rheumatoid arthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009536021A JP2009536021A (ja) | 2009-10-08 |
| JP2009536021A5 true JP2009536021A5 (enExample) | 2010-01-07 |
Family
ID=38581639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009504310A Pending JP2009536021A (ja) | 2006-04-07 | 2007-04-05 | 関節リウマチの患者の末梢血白血球におけるFC受容体媒介性腫瘍壊死因子スーパーファミリ及びケモカインのmRNA発現の増大 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20090311684A1 (enExample) |
| JP (1) | JP2009536021A (enExample) |
| WO (1) | WO2007117589A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1776471B9 (en) * | 2004-05-25 | 2013-12-18 | Hitachi Chemical Company, Ltd. | Method of measuring cancer susceptibility |
| JP4772055B2 (ja) * | 2004-10-20 | 2011-09-14 | 日立化成工業株式会社 | mRNAの定量により薬剤の投与を選定する方法 |
| JP4945554B2 (ja) * | 2005-04-28 | 2012-06-06 | ヒタチ ケミカル リサーチ センター インコーポレイテッド | 食物サプリメントに対する個体変動評価のモデルとしての全血におけるexvivo遺伝子発現 |
| WO2009070442A2 (en) | 2007-11-14 | 2009-06-04 | Hitachi Chemical Co. Ltd. | Fc receptor-mediated tumor necrosis factor superfamily mrna expression in peripheral blood leukocytes |
| US11028443B2 (en) | 2015-08-31 | 2021-06-08 | Showa Denko Materials Co., Ltd. | Molecular methods for assessing urothelial disease |
| CN115851887A (zh) * | 2022-08-08 | 2023-03-28 | 山西中医药大学 | 一种类风湿关节炎中趋化因子表达及定位的检测方法及其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4925572A (en) * | 1987-10-20 | 1990-05-15 | Pall Corporation | Device and method for depletion of the leukocyte content of blood and blood components |
| US4880548A (en) * | 1988-02-17 | 1989-11-14 | Pall Corporation | Device and method for separating leucocytes from platelet concentrate |
| US5210015A (en) * | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| US5491063A (en) * | 1994-09-01 | 1996-02-13 | Hoffmann-La Roche Inc. | Methods for in-solution quenching of fluorescently labeled oligonucleotide probes |
| PT938320E (pt) * | 1996-03-26 | 2010-09-22 | Michael S Kopreski | Método que permite a utilização de arn extracelular extraído de plasma ou de soro para detectar, monitorizar ou avaliar o cancro |
| US5683698A (en) * | 1996-08-02 | 1997-11-04 | New England Deaconess Hospital | Formulation for alleviating symptoms associated with arthritis |
| US7514232B2 (en) * | 1996-12-06 | 2009-04-07 | Becton, Dickinson And Company | Method for detecting T cell response to specific antigens in whole blood |
| US20020006613A1 (en) * | 1998-01-20 | 2002-01-17 | Shyjan Andrew W. | Methods and compositions for the identification and assessment of cancer therapies |
| US20020048566A1 (en) * | 2000-09-14 | 2002-04-25 | El-Deiry Wafik S. | Modulation of cellular apoptosis and methods for treating cancer |
| US7374881B2 (en) * | 2000-10-31 | 2008-05-20 | Hitachi Chemical Research Center, Inc. | Method for collecting and using nuclear mRNA |
| US6993384B2 (en) * | 2001-12-04 | 2006-01-31 | Advanced Bionics Corporation | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
| US7745180B2 (en) * | 2002-04-24 | 2010-06-29 | Hitachi Chemical Co., Ltd. | Device and method for high-throughput quantification of mRNA from whole blood |
| AU2002953533A0 (en) * | 2002-12-24 | 2003-01-16 | Arthron Limited | Fc receptor modulating compounds and compositions |
| EP1776471B9 (en) * | 2004-05-25 | 2013-12-18 | Hitachi Chemical Company, Ltd. | Method of measuring cancer susceptibility |
| JP4945554B2 (ja) * | 2005-04-28 | 2012-06-06 | ヒタチ ケミカル リサーチ センター インコーポレイテッド | 食物サプリメントに対する個体変動評価のモデルとしての全血におけるexvivo遺伝子発現 |
| US7935482B2 (en) * | 2005-09-27 | 2011-05-03 | Source Precision Medicine, Inc. | Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis |
-
2007
- 2007-04-05 WO PCT/US2007/008559 patent/WO2007117589A2/en not_active Ceased
- 2007-04-05 JP JP2009504310A patent/JP2009536021A/ja active Pending
- 2007-04-05 US US12/296,423 patent/US20090311684A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lynch et al. | Clinical improvement of asthma after anthelminthic treatment in a tropical situation | |
| Laube et al. | Frailty in advanced liver disease | |
| Nilsson et al. | The metabolic syndrome–What is it and how should it be managed? | |
| Feary et al. | Experimental hookworm infection: a randomized placebo‐controlled trial in asthma | |
| Kahle et al. | Interaction effects of temperature and ozone on lung function and markers of systemic inflammation, coagulation, and fibrinolysis: a crossover study of healthy young volunteers | |
| Blunt et al. | Serum albumin and colloid osmotic pressure in survivors and nonsurvivors of prolonged critical illness | |
| Palone et al. | Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease | |
| Sood et al. | Adult-onset asthma becomes the dominant phenotype among women by age 40 years. The longitudinal CARDIA study | |
| Herbert et al. | Depression and immunity: a meta-analytic review. | |
| Zhang et al. | Impact of malnutrition and sarcopenia on quality of life in patients with inflammatory bowel disease: a multicentre study | |
| Nair et al. | How to diagnose and phenotype asthma | |
| Santos et al. | Characterisation of immune mediator release during the immediate response to segmental mucosal challenge in the jejunum of patients with food allergy | |
| JP2009536021A5 (enExample) | ||
| Dahlén et al. | Basophil allergen threshold sensitivity, CD‐sens, is a measure of allergen sensitivity in asthma | |
| İlçin et al. | Cross-cultural adaptation and validation of the Turkish version of the pain catastrophizing scale among patients with ankylosing spondylitis | |
| Yamashita et al. | Features of trunk muscle wasting during acute care and physical function recovery with aortic disease | |
| Luijk et al. | Effect of an inhaled adenosine A2A agonist on the allergen‐induced late asthmatic response | |
| Oshitani et al. | Predictive factors for the response of ulcerative colitis patients during the acute-phase treatment | |
| Janczura et al. | Potential roles of psychological and oxidative stress in insulin resistance: a cohort-based study | |
| Rose et al. | Partial body cryotherapy exposure drives acute redistribution of circulating lymphocytes: preliminary findings | |
| Barton et al. | Benign migratory glossitis and allergy | |
| Narenpitak et al. | Prevalence of chronic kidney disease in type 2 diabetes in primary health care unit of Udon Thani province, Thailand | |
| Wang et al. | New animal model of chronic gout reproduces pathological features of the disease in humans | |
| Leung et al. | A randomized, single‐blind and crossover study of an amino acid‐based milk formula in treating young children with atopic dermatitis | |
| Yariktas et al. | Asymptomatic food hypersensitivity prevalence in patients with eczematous external otitis |